FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3166301259> ?p ?o ?g. }

• W3166301259 endingPage "2261" @default.
• W3166301259 startingPage "2248" @default.
• W3166301259 abstract "The recent emergence of the novel coronavirus (SARS-CoV-2) has resulted in a devastating pandemic with global concern. However, to date, there are no regimens to prevent and treat SARS-CoV-2 virus. There is an urgent need to identify novel leads with anti-viral properties that impede viral pathogenesis in the host system. Esculentoside A (EsA), a saponin isolated from the root of Phytolacca esculenta, is known to exhibit diverse pharmacological properties, especially anti-inflammatory activity. To our knowledge, SARS-CoV-2 uses angiotensin converting enzyme 2 (ACE2) to enter host cells. This is mediated through the proteins of SARS-CoV-2, especially the spike glycoprotein receptor binding domain. Thus, our primary goal is to prevent virus replication and binding to the host, which allows us to explore the efficiency of EsA on key surface drug target proteins using the computational biology paradigm approach. Here, the anti-coronavirus activity of EsA in vitro and its potential mode of inhibitory action on the S-protein of SARS-CoV-2 were investigated. We found that EsA inhibited the HCoV-OC43 coronavirus during the attachment and penetration stage. Molecular docking results showed that EsA had a strong binding affinity with the spike glycoprotein from SARS-CoV-2. The results of the molecular dynamics simulation revealed that EsA had higher stable binding with the spike protein. These results demonstrated that Esculentoside A can act as a spike protein blocker to inhibit SARS-CoV-2. Considering the poor bioavailability and low toxicity of EsA, it is suitable as novel lead for the inhibitor against binding interactions of SARS-CoV-2 of S-protein and ACE2." @default.
• W3166301259 created "2021-06-22" @default.
• W3166301259 creator A5000838832 @default.
• W3166301259 creator A5018323894 @default.
• W3166301259 creator A5025095872 @default.
• W3166301259 creator A5072558968 @default.
• W3166301259 creator A5083984064 @default.
• W3166301259 date "2021-07-01" @default.
• W3166301259 modified "2023-10-02" @default.
• W3166301259 title "A potential antiviral activity of Esculentoside A against binding interactions of SARS-COV-2 spike protein and angiotensin converting enzyme 2 (ACE2)" @default.
• W3166301259 cites W1968186783 @default.
• W3166301259 cites W1968400569 @default.
• W3166301259 cites W1980965960 @default.
• W3166301259 cites W1988079980 @default.
• W3166301259 cites W1996054085 @default.
• W3166301259 cites W2037650802 @default.
• W3166301259 cites W2043120072 @default.
• W3166301259 cites W2052038479 @default.
• W3166301259 cites W2071979462 @default.
• W3166301259 cites W2074473216 @default.
• W3166301259 cites W2079754865 @default.
• W3166301259 cites W2118233996 @default.
• W3166301259 cites W2118612771 @default.
• W3166301259 cites W2134967712 @default.
• W3166301259 cites W2135596197 @default.
• W3166301259 cites W2147813409 @default.
• W3166301259 cites W2160310346 @default.
• W3166301259 cites W2160544821 @default.
• W3166301259 cites W2170564629 @default.
• W3166301259 cites W2183696265 @default.
• W3166301259 cites W2284201926 @default.
• W3166301259 cites W2555560015 @default.
• W3166301259 cites W2593436234 @default.
• W3166301259 cites W2731626834 @default.
• W3166301259 cites W2737794706 @default.
• W3166301259 cites W2885538937 @default.
• W3166301259 cites W2894279844 @default.
• W3166301259 cites W3001465255 @default.
• W3166301259 cites W3003217347 @default.
• W3166301259 cites W3004789303 @default.
• W3166301259 cites W3012655066 @default.
• W3166301259 cites W3013800395 @default.
• W3166301259 cites W3014067025 @default.
• W3166301259 cites W3015190630 @default.
• W3166301259 cites W3015861468 @default.
• W3166301259 cites W3023791128 @default.
• W3166301259 cites W3036854260 @default.
• W3166301259 cites W3042206120 @default.
• W3166301259 cites W3042332408 @default.
• W3166301259 cites W3047492318 @default.
• W3166301259 cites W3048714202 @default.
• W3166301259 cites W3080135618 @default.
• W3166301259 cites W3087347658 @default.
• W3166301259 doi "https://doi.org/10.1016/j.ijbiomac.2021.06.017" @default.
• W3166301259 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8183004" @default.
• W3166301259 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34111482" @default.
• W3166301259 hasPublicationYear "2021" @default.
• W3166301259 type Work @default.
• W3166301259 sameAs 3166301259 @default.
• W3166301259 citedByCount "4" @default.
• W3166301259 countsByYear W31663012592022 @default.
• W3166301259 countsByYear W31663012592023 @default.
• W3166301259 crossrefType "journal-article" @default.
• W3166301259 hasAuthorship W3166301259A5000838832 @default.
• W3166301259 hasAuthorship W3166301259A5018323894 @default.
• W3166301259 hasAuthorship W3166301259A5025095872 @default.
• W3166301259 hasAuthorship W3166301259A5072558968 @default.
• W3166301259 hasAuthorship W3166301259A5083984064 @default.
• W3166301259 hasBestOaLocation W31663012591 @default.
• W3166301259 hasConcept C108625454 @default.
• W3166301259 hasConcept C140704245 @default.
• W3166301259 hasConcept C142724271 @default.
• W3166301259 hasConcept C159047783 @default.
• W3166301259 hasConcept C159110408 @default.
• W3166301259 hasConcept C185592680 @default.
• W3166301259 hasConcept C2522874641 @default.
• W3166301259 hasConcept C2775946041 @default.
• W3166301259 hasConcept C2777648638 @default.
• W3166301259 hasConcept C2779134260 @default.
• W3166301259 hasConcept C2780879997 @default.
• W3166301259 hasConcept C3008058167 @default.
• W3166301259 hasConcept C41685203 @default.
• W3166301259 hasConcept C51639874 @default.
• W3166301259 hasConcept C524204448 @default.
• W3166301259 hasConcept C55493867 @default.
• W3166301259 hasConcept C58475186 @default.
• W3166301259 hasConcept C71924100 @default.
• W3166301259 hasConcept C86803240 @default.
• W3166301259 hasConceptScore W3166301259C108625454 @default.
• W3166301259 hasConceptScore W3166301259C140704245 @default.
• W3166301259 hasConceptScore W3166301259C142724271 @default.
• W3166301259 hasConceptScore W3166301259C159047783 @default.
• W3166301259 hasConceptScore W3166301259C159110408 @default.
• W3166301259 hasConceptScore W3166301259C185592680 @default.
• W3166301259 hasConceptScore W3166301259C2522874641 @default.
• W3166301259 hasConceptScore W3166301259C2775946041 @default.
• W3166301259 hasConceptScore W3166301259C2777648638 @default.
• W3166301259 hasConceptScore W3166301259C2779134260 @default.

• next